Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Point Biopharma Global Inc (NQ: PNT ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 12.49 (70) Ask (Size) 12.51 (49) Prev. Close 12.50 Today's Range N/A - N/A 52wk Range 6.570 - 14.35 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned December 27, 2023 With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole... Via Benzinga Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug December 19, 2023 Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c Via Benzinga Performance More News Read More Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today? December 18, 2023 Via Benzinga Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment November 29, 2023 Via FinancialNewsMedia Topics Death Exposures Death Recap: POINT Biopharma Global Q3 Earnings November 13, 2023 Via Benzinga Top 5 Health Care Stocks That May Collapse In November November 17, 2023 Via Benzinga 7 Healthcare Stocks That Are Poised to Become the Next Unicorns November 09, 2023 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 October 24, 2023 Via Benzinga Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race October 17, 2023 Via PressReach POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT October 06, 2023 From Kahn Swick & Foti, LLC Via Business Wire Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review October 06, 2023 Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 October 06, 2023 Via Benzinga Why Point BioPharma Global Stock Skyrocketed 86% This Week October 05, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2023 October 04, 2023 Via Benzinga Why Eli Lilly Stock Was Looking Sickly Today October 03, 2023 Via The Motley Fool Crude Oil Moves Higher; POINT Biopharma Global Shares Jump October 03, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Shares of Point Biopharma Global Are Soaring Tuesday October 03, 2023 Via The Motley Fool Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 03, 2023 Via Benzinga Nasdaq Down Over 200 Points; US Job Openings Rise In August October 03, 2023 Via Benzinga Topics Stocks Exposures US Equities Point Biopharma Stock Nearly Doubles On Eli Lilly Deal October 03, 2023 Via Talk Markets BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS) October 03, 2023 From Brodsky & Smith LLC Via GlobeNewswire 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories October 03, 2023 Via Benzinga Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday October 03, 2023 Via Benzinga Topics Stocks Exposures US Equities Dow Falls Over 100 Points; McCormick Sales Miss Views October 03, 2023 Via Benzinga Topics Earnings Stocks Exposures Financial US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.